Efficacy and Safety of Sintilimab Combined with Nab-PP Plus Rh-endostatin in Locally Advanced/advanced and Recurrent Metastatic Squamous Non-small Cell Lung Cancer: a Single-arm, Multicenter Clinical Study
Clinical trial NCT06747169 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06747169
- Sponsor
- Jian-Guo Zhou, MD, PhD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-17
- Primary completion
- 2026-12-17
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.